Dextromethorphan: Clinical Trials

16 trials of Dextromethorphan, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 4 terminated, 2 withdrawn. 16 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 416Completed 10, Terminated 4, Withdrawn 2

Follow Dextromethorphan: new trials by email Literature Review of Dextromethorphan trials Research Report on Dextromethorphan

Trials (filtered) newest first · largest first

All 16 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dextromethorphan as an Augmentation Agent in Treatment-resistant Schizophrenia
Dextromethorphan, Placebo - Treatment Resistant Schizophrenia
Phase 4CompletedAll India Institute of Medical Sciences, Bhubaneswar402023-08-312025-05-09
Repurposing of Dextromethorphan as an Adjunct Therapy in Patients With Major Depressive Disorder
Selective Serotonin Reuptake Inhibitors, Dextromethorphan, Placebo - Major Depressive Disorder
Phase 4CompletedAll India Institute of Medical Sciences, Bhubaneswar602022-02-102023-12-22
Dextromethorphan Added on for Children With Chronic Irritability
Dextromethorphan, placebo - Irritable Mood
Phase 4CompletedTri-Service General Hospital (TSGH)1202021-05-092026-10-07
Dextromethorphan Use in Multimodal Analgesia Regimens for Total Knee Arthroplasty
Dextromethorphan, Placebo - Concentrate, Acetaminophen - Pain, Postoperative
Phase 4TerminatedUniversity of Southern California232017-01-012019-05-14
Phase 4, Vedolizumab-4002 Post-marketing, Disease-Drug-Drug Interaction Study
Caffeine, Losartan, Omeprazole - Colitis, Ulcerative, Crohn Disease
Phase 4WithdrawnTakeda2016-11-012020-10-27
Effects of Isotretinoin on CYP2D6 Activity
Isotretinoin, dextromethorphan - CYP2D6 Polymorphism
Phase 4CompletedUniversity of Washington332016-07-262025-01-28
Dextromethorphan Pediatric Acute Cough Study
Dextromethorphan Hydrobromide, Placebo, Cough recording device - Cough
Phase 4TerminatedPfizer1312016-02-252021-04-28
Effectiveness, Safety, and Health-Related Outcomes of NUEDEXTA® in Nursing Home Patients With Pseudobulbar Affect (PBA)
NUEDEXTA® - Pseudobulbar Affect (Involuntary Laughing and/or Crying)
Phase 4TerminatedAvanir Pharmaceuticals52015-09-012017-07-03
Evaluation of CYP450 Activities in Diabetic Patients vs. Non-diabetic Subjects
CRCHUM-MT cocktail - Type 2 Diabetes
Phase 4CompletedCentre hospitalier de l'Université de Montréal (CHUM)732015-04-012019-07-23
Antitussive Effect of a Naturally Flavored Syrup Containing Diphenhydramine, Compared With Dextromethorphan and Placebo
diphenhydramine/phenylephrine/cocoa; dextromethorophan; placebo, diphenhydramine/phenylephrine/cocoa; placebo; dextromethorphan, dextromethorphan; diphenhydramine/phenylephrine/cocoa; placebo - Cough Reflex Sensitivity
Phase 4CompletedMontefiore Medical Center222014-01-012018-02-28
Study to Evaluate Effect of Belatacept on Pharmacokinetics of Inje Cocktail in Healthy Volunteers
Caffeine, Losartan, Omeprazole - Transplant Rejection
Phase 4CompletedBristol-Myers Squibb452013-01-012014-06-27
Does Pre and Postoperative Dextromethorphan Reduce Post-tonsillectomy Pain in Children?
Dextromethorphan, Placebo - Pain, Postoperative
Phase 4CompletedDr. Rachel Rooney852012-03-012020-09-21
Acute Cough Study In Children
Dextromethorphan, Placebo - Common Cold, Infections, Upper Respiratory Tract
Phase 4TerminatedPfizer1402010-12-012012-09-20
Assessment of Opioid Analgesia in Sickle Cell
Dextromethorphan, Codeine, Morphine - Sickle Cell Disease
Phase 4WithdrawnChildren's National Research Institute2006-11-012014-12-23
Treatment of Acute Sinusitis
Acetaminophen, Amoxicillin, Dextromethorphan hydrobromide with guaifenesin - Acute Respiratory Infections, Acute Rhinosinusitis
Phase 4CompletedWashington University School of Medicine1722006-10-012012-12-28
Vascular Endothelial Protection Effects of Dextromethorphan
Dextromethorphan - Atherosclerosis, Smoking
Phase 4CompletedNational Cheng-Kung University Hospital402005-03-012008-01-31

Conditions studied

Cough (3)  ·  Pain, Postoperative (2)  ·  Anemia, Sickle Cell (1)  ·  Atherosclerosis (1)  ·  Colitis, Ulcerative (1)  ·  Common Cold (1)  ·  Crohn Disease (1)  ·  Depressive Disorder, Major (1)  ·  Diabetes Mellitus (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Inflammation (1)  ·  Respiratory Tract Infections (1)  ·  Rhinosinusitis (1)  ·  Schizophrenia, Treatment-Resistant (1)  ·  Sinusitis (1)

Sponsors

All India Institute of Medical Sciences, Bhubaneswar (2)  ·  Pfizer (2)  ·  Avanir Pharmaceuticals (1)  ·  Bristol-Myers Squibb (1)  ·  Centre hospitalier de l'Université de Montréal (CHUM) (1)  ·  Children's National Research Institute (1)  ·  Dr. Rachel Rooney (1)  ·  Montefiore Medical Center (1)  ·  National Cheng-Kung University Hospital (1)  ·  Takeda (1)  ·  Tri-Service General Hospital (TSGH) (1)  ·  University of Southern California (1)  ·  University of Washington (1)  ·  Washington University School of Medicine (1)

Countries

United States (9)  ·  India (2)  ·  Taiwan (2)  ·  Canada (1)

Top investigators

Chin-Bin Yeh, M.D., Ph.D. (1)  ·  Hanna Schittek, MD (1)  ·  Jane Garbutt, MB, ChB (1)  ·  Jean-Louis Chiasson, MD (1)  ·  Julia C. Finkel, M.D. (1)  ·  Mary F Hebert, PharmD (1)  ·  Ping-Yen Liu, MD, PhD (1)  ·  Rachel Rooney, MD, FRCPC (1)  ·  Rituparna Maiti, M.D. (1)  ·  Veronique Michaud, BPharm, PhD (1)

Results publications

PMID 21844413, PMID 22337680, PMID 25673148, PMID 28194724, PMID 28916283, PMID 29439084, PMID 29532791, PMID 29660207, PMID 31099895, PMID 32755625, PMID 33070149, PMID 33904154, PMID 34242798, PMID 37864393, PMID 38688675, PMID 39551007, PMID 41780197

NIH funding

R01GM124264 (1), U01AI064655 (1)